News for BMKDF Stock

BioMark Diagnostics Announces Breakthrough Publication Reinforcing Leadership in AI-Powered Metabolomics for Oncology BioMark Diagnostics Announces Landmark Publication Validating High Specificity and Accuracy of Its Early-Stage Lung Cancer Test BioMark Diagnostics Announces Uplisting to OTCQB Venture Market BioMark Diagnostics Underscores Commitment to Rare Disease Research on Rare Disease Day 2025 BioMark's Liquid Biopsy Platform Takes A Major Step Forward in Breast Cancer Diagnosis with AI-powered ER Status Prediction BioMark Expands Its Liquid Biopsy Platform with Two Groundbreaking Publications in Breast Cancer Detection BioMark Diagnostics and Principal Investigators Publish an Important Approach Using Metabolomics and ML to Identify Biomarkers for NEN BioMark Diagnostics Completes Testing of over 5,400 Subjects as Part of a Validation Study for Early Lung Cancer Detection Biomark Diagnostics to Showcase Innovative Liquid Biopsy Technology at H.C. Wainwright's 26th Annual Global Investment Conference in New York The U.S. Patent and Trademark Office Grants BioMark Patent That Expands Its Claims Covering Its Legacy Liquid Biopsy Assay BioMark Diagnostics Announces Presentation of Promising Glioblastoma Research at 2024 GPEN Conference BioMark Announces Warrant Extension and Granting of Options BioMark to Advance Development of Cancer Treatment for Glioblastoma BioMark Partners with Rubix LS to Advance Blood-Based Cancer Screening in Underserved Communities Theresa Peterson Joins Biomark's Advisory Team BioMark Announces Closing of $1.9 Million Non-Brokered Private Placement BioMark Announces Recent New Patent Granted in Canada to Support Its Liquid Biopsy Based Legacy Assay BioMark Provides Second Quarter Operational Update and Announces Extension to Warrant Exercise Term BioMark Strengthens and Expands Its Strategic Advisory Team in Pursuit of Commercialization Initiatives BioMark Announces Financial Contribution from the City of Quebec to Support Commercialization Initiatives of Its Proprietary Lung Cancer Detection Test BioMark to Unveil Results of Its Early Breast Cancer Study at the Upcoming San Antonio Breast Cancer Symposium BioMark Appoints Kevin J. Cosgriff to Its Strategic Advisory Team Japan Patent Office (JPO) Issued BioMark Patent with Claims Covering Its Lung Cancer Urine Based Liquid Biopsy Assay BioMark Issues Statement on Recent Market Activity and Provides a Brief Corporate Update BioMark Unveils Significant Scientific Advancements from Its Leading Liquid Biopsy Technology at ASCO 2023 Annual Meeting BioMark Announces the U.S. Patent and Trademark Office Granted Patent with Claims Covering Its Lung Cancer Liquid Biopsy Assay